The New Jersey Department of Health (NJDOH) Tuberculosis (TB) Program conducts statewide surveillance by housing and maintaining the state TB disease registry. Additionally, the program provides financial assistance, direct assistance, material support, technical assistance, and education to strengthen TB prevention and control activities at local health departments throughout the state.
The NJDOH TB Program ensures continuity of care by tracking TB case-patients migrating in to and out of New Jersey and the United States. The program also provides health service grant funding to partially fund eight regional TB clinics. Local TB programs are funded through a combination of sources unique to each site: levies, general revenue funds, private hospitals, and endowments from corporate or community groups. Where needed, the NJDOH TB Program provides on-site expert guidance for the investigation of TB cases, clusters and outbreaks, and conducts regional trainings to address specific needs. Expert TB medical consultation for complex cases is provided by the Global TB Institute and the TB Medical Advisory Board. The Global TB Institute in Newark has been designated a TB Center of Excellence by the CDC and serves as a federally funded regional training and medical consultation consortia, providing trainings and webinars for public health nurses and TB clinicians throughout New Jersey and the Northeastern United States.
New Jersey is the fourth smallest and most densely populated state, with approximately 1,200 people per square mile. In 2017, the population was 8.9 million; 51.2 percent females and 48.8 percent males. The largest segment of the population is White (58%) followed by Hispanic (18%), Black (15%), and Asian (9%). Approximately 23 percent of the population is foreign-born.
The incidence of TB has been generally declining in New Jersey since 1992. There has been a 70.4 percent decrease in TB morbidity in New Jersey since 1992 (The peak of TB resurgence in the US). More recently, the rate of decline has begun to slow or level off with a 28.1 percent decrease in TB morbidity since 2009 (10-year Trend) and an 5.2 percent decrease in TB morbidity since 2014 (5-year trend).